Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 15 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | yes | yes: 8, no: 6 |
NetGPI | no | yes: 0, no: 14 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: A4HA48
Term | Name | Level | Count |
---|---|---|---|
GO:0000413 | protein peptidyl-prolyl isomerization | 7 | 2 |
GO:0006457 | protein folding | 2 | 2 |
GO:0006807 | nitrogen compound metabolic process | 2 | 2 |
GO:0008152 | metabolic process | 1 | 2 |
GO:0009987 | cellular process | 1 | 2 |
GO:0018193 | peptidyl-amino acid modification | 5 | 2 |
GO:0018208 | peptidyl-proline modification | 6 | 2 |
GO:0019538 | protein metabolic process | 3 | 2 |
GO:0036211 | protein modification process | 4 | 2 |
GO:0043170 | macromolecule metabolic process | 3 | 2 |
GO:0043412 | macromolecule modification | 4 | 2 |
GO:0044238 | primary metabolic process | 2 | 2 |
GO:0061077 | chaperone-mediated protein folding | 3 | 2 |
GO:0071704 | organic substance metabolic process | 2 | 2 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003755 | peptidyl-prolyl cis-trans isomerase activity | 3 | 15 |
GO:0003824 | catalytic activity | 1 | 15 |
GO:0016853 | isomerase activity | 2 | 15 |
GO:0016859 | cis-trans isomerase activity | 3 | 15 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 15 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 178 | 182 | PF00656 | 0.350 |
CLV_NRD_NRD_1 | 72 | 74 | PF00675 | 0.451 |
CLV_PCSK_KEX2_1 | 72 | 74 | PF00082 | 0.451 |
CLV_PCSK_SKI1_1 | 52 | 56 | PF00082 | 0.485 |
CLV_PCSK_SKI1_1 | 8 | 12 | PF00082 | 0.325 |
DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.479 |
DOC_CYCLIN_yCln2_LP_2 | 136 | 142 | PF00134 | 0.290 |
DOC_PP2B_LxvP_1 | 136 | 139 | PF13499 | 0.312 |
DOC_USP7_MATH_1 | 156 | 160 | PF00917 | 0.386 |
DOC_USP7_MATH_1 | 57 | 61 | PF00917 | 0.429 |
DOC_WW_Pin1_4 | 110 | 115 | PF00397 | 0.367 |
DOC_WW_Pin1_4 | 168 | 173 | PF00397 | 0.380 |
DOC_WW_Pin1_4 | 187 | 192 | PF00397 | 0.387 |
LIG_14-3-3_CanoR_1 | 3 | 8 | PF00244 | 0.550 |
LIG_14-3-3_CanoR_1 | 40 | 45 | PF00244 | 0.453 |
LIG_Clathr_ClatBox_1 | 67 | 71 | PF01394 | 0.339 |
LIG_FHA_1 | 14 | 20 | PF00498 | 0.446 |
LIG_FHA_1 | 194 | 200 | PF00498 | 0.350 |
LIG_FHA_1 | 21 | 27 | PF00498 | 0.571 |
LIG_FHA_2 | 174 | 180 | PF00498 | 0.351 |
LIG_GBD_Chelix_1 | 14 | 22 | PF00786 | 0.297 |
LIG_IBAR_NPY_1 | 106 | 108 | PF08397 | 0.199 |
LIG_LIR_Gen_1 | 200 | 204 | PF02991 | 0.510 |
LIG_LIR_Gen_1 | 43 | 51 | PF02991 | 0.361 |
LIG_LIR_Nem_3 | 132 | 137 | PF02991 | 0.317 |
LIG_LIR_Nem_3 | 200 | 204 | PF02991 | 0.510 |
LIG_LIR_Nem_3 | 43 | 47 | PF02991 | 0.370 |
LIG_NRBOX | 16 | 22 | PF00104 | 0.420 |
LIG_SH2_STAT3 | 183 | 186 | PF00017 | 0.295 |
LIG_SH2_STAT5 | 137 | 140 | PF00017 | 0.373 |
LIG_SH2_STAT5 | 183 | 186 | PF00017 | 0.469 |
LIG_SH2_STAT5 | 44 | 47 | PF00017 | 0.340 |
LIG_SH2_STAT5 | 90 | 93 | PF00017 | 0.259 |
LIG_SH3_3 | 185 | 191 | PF00018 | 0.376 |
LIG_SUMO_SIM_anti_2 | 16 | 23 | PF11976 | 0.402 |
LIG_SUMO_SIM_par_1 | 16 | 23 | PF11976 | 0.397 |
LIG_SUMO_SIM_par_1 | 25 | 30 | PF11976 | 0.377 |
LIG_TYR_ITIM | 199 | 204 | PF00017 | 0.482 |
LIG_Vh1_VBS_1 | 11 | 29 | PF01044 | 0.320 |
MOD_CDK_SPxxK_3 | 168 | 175 | PF00069 | 0.368 |
MOD_CK1_1 | 173 | 179 | PF00069 | 0.384 |
MOD_CK1_1 | 32 | 38 | PF00069 | 0.485 |
MOD_CK2_1 | 173 | 179 | PF00069 | 0.362 |
MOD_GlcNHglycan | 172 | 175 | PF01048 | 0.606 |
MOD_GlcNHglycan | 59 | 62 | PF01048 | 0.404 |
MOD_GlcNHglycan | 63 | 66 | PF01048 | 0.432 |
MOD_GSK3_1 | 170 | 177 | PF00069 | 0.463 |
MOD_GSK3_1 | 25 | 32 | PF00069 | 0.397 |
MOD_GSK3_1 | 57 | 64 | PF00069 | 0.477 |
MOD_N-GLC_1 | 57 | 62 | PF02516 | 0.433 |
MOD_NEK2_1 | 20 | 25 | PF00069 | 0.376 |
MOD_NEK2_1 | 88 | 93 | PF00069 | 0.295 |
MOD_NEK2_2 | 156 | 161 | PF00069 | 0.199 |
MOD_PIKK_1 | 112 | 118 | PF00454 | 0.413 |
MOD_PKA_2 | 2 | 8 | PF00069 | 0.564 |
MOD_PKB_1 | 40 | 48 | PF00069 | 0.338 |
MOD_Plk_1 | 29 | 35 | PF00069 | 0.620 |
MOD_Plk_1 | 57 | 63 | PF00069 | 0.440 |
MOD_Plk_4 | 13 | 19 | PF00069 | 0.401 |
MOD_Plk_4 | 29 | 35 | PF00069 | 0.301 |
MOD_ProDKin_1 | 110 | 116 | PF00069 | 0.367 |
MOD_ProDKin_1 | 168 | 174 | PF00069 | 0.370 |
MOD_ProDKin_1 | 187 | 193 | PF00069 | 0.385 |
MOD_SUMO_for_1 | 194 | 197 | PF00179 | 0.321 |
MOD_SUMO_rev_2 | 147 | 155 | PF00179 | 0.276 |
TRG_DiLeu_BaEn_1 | 123 | 128 | PF01217 | 0.259 |
TRG_ENDOCYTIC_2 | 201 | 204 | PF00928 | 0.526 |
TRG_ENDOCYTIC_2 | 44 | 47 | PF00928 | 0.373 |
TRG_NES_CRM1_1 | 116 | 130 | PF08389 | 0.373 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1II12 | Leptomonas seymouri | 68% | 100% |
A0A1X0P7N1 | Trypanosomatidae | 38% | 96% |
A0A3Q8IB31 | Leishmania donovani | 32% | 100% |
A0A3S5H764 | Leishmania donovani | 77% | 100% |
A0A3S5IR72 | Trypanosoma rangeli | 38% | 100% |
A4H677 | Leishmania braziliensis | 32% | 100% |
A4HUK1 | Leishmania infantum | 32% | 100% |
A4HYB4 | Leishmania infantum | 76% | 100% |
D0A0P0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 30% | 100% |
E9AN99 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 31% | 100% |
E9AS47 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 76% | 100% |
Q09734 | Trypanosoma cruzi | 40% | 100% |
Q4QDB9 | Leishmania major | 77% | 99% |
Q4QHC5 | Leishmania major | 32% | 100% |